Lenalidomide Adherence in Older Adults

Stopped early

Conditions studied: Multiple Myeloma

In brief

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.

Key facts

Study ID

NCT03779555

Run by

Washington University School of Medicine

People needed

17

Starts

2019-12-13

Expected to finish

2020-08-31

Last updated by the study team

2020-10-22

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥65
• Receiving lenalidomide for treatment of multiple myeloma.
• Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
• Able to read and understand English.
• Able to understand and willing to sign an IRB-approved written informed consent document.

You may not qualify if…

• Estimated life expectancy <6 months.
• Anticipated duration of lenalidomide therapy <3 months.
• Residing in a nursing facility where their medications are administered to them OR patient reports they do not self-administer their own medications.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.